• PDF / 169,144 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 59 Downloads / 154 Views

DOWNLOAD

REPORT

---

1 S

SARS-CoV-2 infection: case report In a study of 29 patients (aged 0–16 years), performed between 23 February 2020 and 24 April 2020, a patient [age and sex not stated] was described, who developed SARS-CoV-2 infection while receiving treatment with brentuximab-vedotin and nivolumab for a refractory Hodgkin lymphoma [routes, dosages, duration of treatments to reaction onsets and outcome not stated]. The patient, who was diagnosed with refractory Hodgkin lymphoma started receiving immunotherapy with brentuximab-vedotin and nivolumab. However, the patient developed SARS-CoV-2 infection. Bisogno G, et al. Clinical Characteristics and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italian Pediatric Oncology Patients: A Study From the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica. Journal of the Pediatric Infectious Diseases Society 9: 530-534, No. 803519881 5, Nov 2020. Available from: URL: http://doi.org/10.1093/jpids/piaa088

0114-9954/20/1834-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 12 Dec 2020 No. 1834